🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tom Loosli

University of Zurich

ORCID: 0000-0003-2049-3562

Also affiliated with University Hospital Zurich

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.261Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

medRxiv(2023)10.1101/2023.04.05.23288183
Top 59%
0.261DataRank
Top 59%3 citations

Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton +13 more

Papers

Driven by 10 papers — median percentile 41. Top paper: “HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis”.

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

The Lancet HIV(2023)10.1016/s2352-3018(23)00228-x
N/A
0.734DataRank · unranked
132 citations

Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton +13 more

Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study

The Lancet Global Health(2025)10.1016/s2214-109x(24)00553-9
N/A
0.494DataRank · unranked
26 citations

Na Han, Anthony Hauser, Johannes Josi, Suzanne M Ingle, Ard van Sighem +12 more

Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1

Journal of Antimicrobial Chemotherapy(2023)10.1093/jac/dkac430
N/A
0.442DataRank · unranked
18 citations

Tom Loosli, Maryam Zaheri, Paul Frischknecht, Michael Huber, Katharina Kusejko +19 more

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)

BMJ Open(2024)10.1136/bmjopen-2024-085819
N/A
0.292DataRank · unranked
6 citations

Mamatha Sauermann, Tom Loosli, Stefanie Hossmann, Selma Riedo, Niko Beerenwinkel +7 more

HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

medRxiv(2023)10.1101/2023.04.05.23288183
Top 59%
0.261DataRank
Top 59%3 citations

Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton +13 more

Predicting emergent Dolutegravir resistance in South Africa: A modelling study

medRxiv(2024)10.1101/2024.07.20.24310740
N/A
0.104DataRank · unranked
1 citations

Anthony Hauser, Johannes Josi, Na Han, Suzanne M Ingle, Ard van Sighem +12 more

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)

medRxiv(2024)10.1101/2024.05.23.24307850
N/A
0DataRank · unranked
0 citations

Mamatha Sauermann, Tom Loosli, Stefanie Hossmann, Selma Riedo, Niko Beerenwinkel +7 more

HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae569
N/A
0DataRank · unranked
14 citations

J.H. Meier, Marcel Stoeckle, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini +55 more

The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study

The Lancet Global Health(2025)10.1016/s2214-109x(25)00350-x
N/A
0DataRank · unranked
3 citations

Tom Loosli, Nanina Anderegg, Anthony Hauser, Johannes Josi, Mary‐Ann Davies +6 more

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence

Clinical Infectious Diseases(2025)10.1093/cid/ciaf444
N/A
0DataRank · unranked
2 citations

Richard Lessells, Winnie Muyindike, Lyra S. Johnson, Roger D. Kouyos, Tom Loosli +10 more